DNA Vaccines Market - Forecast(2020 - 2025)

Report Code: HCR 0280 Report Format: PDF + Excel (Delivery in 48 Hrs)
DNA Vaccines Market is forecast to reach revenue of $9.43 Billion by 2025, growing at a CAGR of 33.86% during the forecast period 2020-2025. DNA vaccines are composed of deoxyribonucleic acid, which encodes antigens and stimulates a wider range of immune responses in the body with few side effects. DNA based Vaccines concept deliver to cells after which the gene is expressed and can generate the protein of interest. Clinical trials of some DNA vaccines have shown promising results in the treatment of several types of cancers like metastatic melanoma, prostate carcinoma, pancreatic cancer, and other solid tumors. The demand for DNA Vaccines is experiencing rapid growth owing to factors such as adoption of DNA Vaccines in Healthcare, Low cost, Increasing Technology, fewer side effects, increasing awareness about Health professionals and others. With the rise of COVID-19 pandemic throughout the world 

Key Takeaways
  • North America dominates the DNA Vaccines Market owing to the increasing prevalence of infectious diseases in countries such as U.S and Canada.
  • Adoption of DNA Vaccines in Healthcare, Low cost, Increasing Technology, fewer side effects, increasing awareness about Health professionals are some of the key factors which are leading the demand for DNA Vaccines.
  • With the current COVID-19 Outbreak there is a huge demand for vaccination that can hack to build better immunity in order to fight the virus
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the DNA Vaccines Market.

By Type – Segment Analysis 
Based on the types, the DNA Vaccines Market is segmented into Human DNA Vaccines and Animal DNA Vaccines. Animal DNA vaccine is dominating the market in 2019 and is estimated to grow at a CAGR of 19.8% during the forecast period 2020-2025. This is owing to the unavailability of human DNA vaccines in the market along with the rising incidence of canine melanoma and other animal diseases. Animal vaccines are third generation vaccines and contain DNA that codes for specific proteins from a pathogen. This DNA is injected into host body and produces protein for which the body generates immune response. Moreover, the strong pipeline of human targeted vaccines is likely to aid in the market growth

By Application – Segment Analysis
Based on the applications, DNA Vaccines Market is segmented into Human Diseases which includes applications in Oncology, Infectious Disease, Allergies, and Veterinary Disease. The Veterinary Disease based on application is forecast to grow at a higher CAGR during the forecast period 2020-2025 owing to availability of DNA vaccines for animal diseases that includes canine melanoma vaccine (DOG), West Nile Innovator (Horse), Life tide-SW5 (Swine and other food animals) and Apex-IHN (Salmon fish). 
 
By Geography – Segment Analysis
Based on the geography the DNA Vaccines Market has covered globally viz North America, South America, Europe, Asia Pacific (APAC) and Rest of World (ROW). The Market in North America accounts for 43.7% of the total market share, which is attributed by government initiatives to immune citizens, coupled with high awareness regarding the benefits of genetic vaccines targeted towards animals. 

Asia Pacific region is set to be the highest growth during the forecast period 2020-2025 owing to rising awareness of people regarding the advantages of immunization against HPV and Hepatitis B. Additionally, it is estimated that the DNA Vaccines Market is set to grow exponentially during the forecast period 2020-2025 owing to COVID-19 outbreak.

Market Drivers - DNA Vaccines Market

  • Rising Demand for effective treatment of infectious disease in driving market
DNA Vaccines used to kill and stop the growth of microorganisms. These drugs can act as a defense system for the human body and neutralize the action of disease causative agents. With increasing research activities and Increasing awareness and extensive R&D drugs, there is rising demand for treatment of infectious diseases

Challenges - DNA Vaccines Market
The main area of uncertainty is related to the immunological impact, tissue distribution and persistence after injection and whether the DNA vaccine can leak into the environment. This, in turn, create a challenging point for the growth of DNA Vaccine. Also, with, the limited efficiency of plasmid-based techniques precluded their use in the creation of more accurate human cell models is one of the challenges for DNA Vaccine Market

Vitamin & Mineral Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the DNA Vaccines Market. In 2019, DNA Vaccines Market share is consolidated by the top ten players present in the market. DNA Vaccines Market Top 10 companies include Inovio Biomedical Corp, Merck & Co., Mitsubishi Tanabe, Dendreon Corporation, ASTELLAS PHARMA, Dynavax Technologies, Sanofi, Tekmira Pharmaceuticals GlaxoSmithKline Corp, Protein Sciences Corp.among others.

Acquisitions/Product Launches
  • In February 2020, Merck& Co announced the formation of a new, independent publicly-traded company focused on its Women’s Health, trusted Legacy Brands, and Biosimilars business. 
  • In February 2019, Merck & Co announced its acquisition of Immune Design Corp for nearly $300 million, gaining access to its immunotherapy programs.

1. DNA Vaccines Market Overview
    1.1 Definitions and Scope
2. DNA Vaccines Market - Executive Summary
    2.1 Market Revenue, and Key Trends by Company
    2.2 Key trends by Type
    2.3 Key trends by Technology
    2.4 Key trends by Application
    2.5 Key trends by Geography
3. DNA Vaccines Market – Comparative Analysis
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis - Key Companies
    3.5 Pricing Analysis
4. DNA Vaccines Market- Startup companies Scenario Premium (Premium)
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. DNA Vaccines Market- Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. DNA Vaccines Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. DNA Vaccines Market- Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. DNA Vaccines Market – By Type (Market Size -$Million/$Billion)
    8.1 DNA Vaccines for Humans
    8.2 DNA Vaccines for Animals
9. DNA Vaccines Market – By Technology (Market Size -$Million/$Billion)
    9.1 Plasmid DNA Vaccines Technology 
        9.1.1 Therapeutic Technology 
        9.1.2 Preventive Technology 
    9.2 Plasmid DNA Delivery Technology
        9.2.1 Uncomplexed Plasmid DNA
        9.2.2 Liposomes
        9.2.3 Gold Particles
        9.2.4 Electroporation
        9.2.5 Bacteriophages
        9.2.6 Bacterial ghosts
        9.2.7 Nanoparticles
        9.2.8 Viruses
10. DNA Vaccines Market – By Application (Market Size -$Million/$Billion)
    10.1 Human Diseases
        10.1.1 Oncology
            10.1.1.1 Pancreatic Cancer
            10.1.1.2 Breast Cancer
            10.1.1.3 Ovarian Cancer
            10.1.1.4 Small cell lung Cancer
            10.1.1.5 Melanoma
            10.1.1.6 Others
        10.1.2 Infectious Diseases
            10.1.2.1 Cytomegalovirus (CMV)
            10.1.2.2 Hepatitis B (HBV)
            10.1.2.3 Hepatitis C (HCV)
            10.1.2.4 Human Immunodeficiency Virus (HIV)
            10.1.2.5 Influenza
            10.1.2.6 Others
        10.1.3 Allergies
        10.1.4 Others
    10.2 Veterinary Disease
        10.2.1 Canine Melanoma
        10.2.2 Leishmaniasis
        10.2.3 Equine West Nile Virus
        10.2.4 Others
    10.3 Others
11. DNA Vaccines Market - By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 South America
        11.2.1 Brazil
        11.2.2 Argentina
        11.2.3 Rest of South America
    11.3 Europe
        11.3.1 U.K.
        11.3.2 Germany
        11.3.3 France
        11.3.4 Italy
        11.3.5 Spain
        11.3.6 Rest of Europe
    11.4 Asia-Pacific
        11.4.1 China
        11.4.2 Japan
        11.4.3 South Korea
        11.4.4 India
        11.4.5 Australia & New Zealand
        11.4.6 Rest of Asia Pacific
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
        11.5.3 South America
12. DNA Vaccines Market – Entropy
13. DNA Vaccines Market - Industry / Segment Competition landscape Premium (Premium)
    13.1 Market Share Analysis
        13.1.1 Market Share by Country- Key companies
        13.1.2 Market Share by Region- Key companies
        13.1.3 Market Share at Global Level- Key companies
        13.1.4 Best Practices for Companies
14. DNA Vaccines Market - Key Company List by Country Premium (Premium)
15. DNA Vaccines Market Company Analysis
    15.1 Inovio Biomedical Corp.
    15.2 Merck & Co.
    15.3 Mitsubishi Tanabe
    15.4 Dendreon Corporation
    15.5 ASTELLAS PHARMA
    15.6 Dynavax Technologies
    15.7 Sanofi
    15.8 Tekmira Pharmaceuticals
    15.9 GlaxoSmithKline Corp
    15.10 Protein Sciences Corp.
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: DNA Vaccines Market Overview 2019-2024
Table 2: DNA Vaccines Market Leader Analysis 2018-2019 (US$)
Table 3: DNA Vaccines Market Product Analysis 2018-2019 (US$)
Table 4: DNA Vaccines Market End User Analysis 2018-2019 (US$)
Table 5: DNA Vaccines Market Patent Analysis 2013-2018* (US$)
Table 6: DNA Vaccines Market Financial Analysis 2018-2019 (US$)
Table 7: DNA Vaccines Market Driver Analysis 2018-2019 (US$)
Table 8: DNA Vaccines Market Challenges Analysis 2018-2019 (US$)
Table 9: DNA Vaccines Market Constraint Analysis 2018-2019 (US$)
Table 10: DNA Vaccines Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: DNA Vaccines Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: DNA Vaccines Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: DNA Vaccines Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: DNA Vaccines Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: DNA Vaccines Market Value Chain Analysis 2018-2019 (US$)
Table 16: DNA Vaccines Market Pricing Analysis 2019-2024 (US$)
Table 17: DNA Vaccines Market Opportunities Analysis 2019-2024 (US$)
Table 18: DNA Vaccines Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: DNA Vaccines Market Supplier Analysis 2018-2019 (US$)
Table 20: DNA Vaccines Market Distributor Analysis 2018-2019 (US$)
Table 21: DNA Vaccines Market Trend Analysis 2018-2019 (US$)
Table 22: DNA Vaccines Market Size 2018 (US$)
Table 23: DNA Vaccines Market Forecast Analysis 2019-2024 (US$)
Table 24: DNA Vaccines Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: DNA Vaccines Market By Type, Revenue & Volume, By DNA vaccines for humans, 2019-2024 ($)
Table 27: DNA Vaccines Market By Type, Revenue & Volume, By DNA vaccines for animals, 2019-2024 ($)
Table 28: North America DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 29: South america DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 30: Europe DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 31: APAC DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 32: Middle East & Africa DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 33: Russia DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 34: Israel DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 35: Top Companies 2018 (US$)DNA Vaccines Market, Revenue & Volume
Table 36: Product Launch 2018-2019DNA Vaccines Market, Revenue & Volume
Table 37: Mergers & Acquistions 2018-2019DNA Vaccines Market, Revenue & Volume


List of Figures

Figure 1: Overview of DNA Vaccines Market 2019-2024
Figure 2: Market Share Analysis for DNA Vaccines Market 2018 (US$)
Figure 3: Product Comparison in DNA Vaccines Market 2018-2019 (US$)
Figure 4: End User Profile for DNA Vaccines Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in DNA Vaccines Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in DNA Vaccines Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in DNA Vaccines Market 2018-2019
Figure 8: Ecosystem Analysis in DNA Vaccines Market 2018
Figure 9: Average Selling Price in DNA Vaccines Market 2019-2024
Figure 10: Top Opportunites in DNA Vaccines Market 2018-2019
Figure 11: Market Life Cycle Analysis in DNA Vaccines Market
Figure 12: GlobalBy TypeDNA Vaccines Market Revenue, 2019-2024 ($)
Figure 13: Global DNA Vaccines Market - By Geography
Figure 14: Global DNA Vaccines Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global DNA Vaccines Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 17: US DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 59: U.K DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 92: China DNA Vaccines Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)DNA Vaccines Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa DNA Vaccines Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)DNA Vaccines Market
Figure 130: Developments, 2018-2019*DNA Vaccines Market
Figure 131: Company 1 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)